The CDKN2A gene, which codes for the Cdk4 inhibitor p16Ink4a, was prominently associated with T2D, raising the possibility that Cdk4 — the primary substrate for p16Ink4a — may be involved in glucose disposal and insulin sensitivity. Here, CDKN2A is linked to type 2 diabetes mellitus.